IMARC Group, a leading market research company, has recently releases report titled “Xerostomia (Dry Mouth Disease) Therapeutics Market Report by Type (Artificial Saliva/Saliva Substitutes, Salivary Stimulants), Drug Type (OTC, Prescription), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global xerostomia therapeutics market share.
How Big is the Xerostomia (Dry Mouth Disease) Therapeutics Market?
The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032.
Industry Overview of Xerostomia (Dry Mouth Disease) Therapeutics
Xerostomia dry mouth disease therapeutics refer to a range of medical treatments and interventions that focus on alleviating the symptoms and addressing the underlying causes of xerostomia, which is commonly known as dry mouth disease. They are cost-effective, convenient to use, and widely available as saliva stimulating medications, saliva substitutes, oral lubricants, chewing gum and lozenges, and prescription toothpaste and mouthwash. They can help stimulate the production of saliva in individuals and provide relief from dry mouth symptoms while improving overall oral comfort. They prevent dental issues, such as cavities, tooth decay, and gum disease, and maintain oral health. As they are beneficial in maintaining oral moisture and alleviating dryness and discomfort, the demand for xerostomia dry mouth disease therapeutics is increasing across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/xerostomia-therapeutics-market/requestsample
What are the growth prospects and trends in the xerostomia (dry mouth disease) therapeutics industry?
At present, the rising prevalence of xerostomia among the masses represents one of the key factors impelling the market growth. Moreover, the increasing development of innovative and patient-friendly treatment options is strengthening the market growth. Apart from this, the escalating demand for sustainable and eco-friendly solutions that reduce environmental impact, along with the rising focus on enhancing patient comfort and quality of life, is positively influencing the market.
In addition, increasing preferences for natural and bio-based ingredients in xerostomia therapeutics that are chemical-free are contributing to the market growth. Besides this, advancements in drug delivery systems and formulation technologies for more effective and convenient dry mouth therapeutics are supporting the growth of the market. Furthermore, the rising awareness about the early diagnosis of xerostomia among individuals is providing lucrative growth opportunities to industry investors.
In line with this, the rising focus on dental hygiene and preventive care among people is propelling the market growth. Additionally, the growing demand for xerostomia dry mouth disease therapeutics among the geriatric population, as they are more prone to dry mouth, is offering a favorable market outlook.
Leading Companies Operating in the Global Xerostomia (Dry Mouth Disease) Therapeutics Industry:
- 3M Company
- Biotene (GSK plc)
- Parnell Pharmaceuticals Inc.
- Quest Products LLC
- Saliwell Ltd
- Sun Pharmaceutical Industries Limited
- West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).
Xerostomia (Dry Mouth Disease) Therapeutics Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Artificial Saliva/Saliva Substitutes
- Salivary Stimulants
Breakup by Drug Type:
- OTC
- Prescription
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
